Literature DB >> 1295755

Clinical relevance of antimicrobial susceptibility testing.

S M Finegold1.   

Abstract

In recent years, significant resistance to antimicrobial agents has been encountered among certain anaerobic bacteria. Susceptibility patterns vary from region to region, but even within a given region susceptibility is not always predictable. Initially, therapy of mixed anaerobic infections must be empirical, based on the nature of the infection, the usual flora of such infections, anticipated modification of this flora by pathophysiologic processes or prior antimicrobial therapy, and evaluation of Gram stains from appropriate specimens. If the infection does not respond well or the patient requires long-term therapy, antimicrobial susceptibility testing may be indicated in order to provide optimum therapy. Susceptibility testing is also indicated for determination of the usual patterns in a particular hospital, for monitoring geographical patterns, and to determine the activity of new antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1295755     DOI: 10.1007/bf01967793

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  20 in total

Review 1.  Susceptibility testing of anaerobic bacteria.

Authors:  S M Finegold
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

2.  Bacteroidaceae bacteremia: clinical experience with 112 patients.

Authors:  A W Chow; L B Guze
Journal:  Medicine (Baltimore)       Date:  1974-03       Impact factor: 1.889

3.  Bacteroides infections.

Authors:  E R Nobles
Journal:  Ann Surg       Date:  1973-05       Impact factor: 12.969

Review 4.  Antimicrobial resistance in Bacteroides.

Authors:  H M Wexler; S M Finegold
Journal:  J Antimicrob Chemother       Date:  1987-02       Impact factor: 5.790

5.  Bacteroides gracilis, an important anaerobic bacterial pathogen.

Authors:  C C Johnson; J F Reinhardt; M A Edelstein; M E Mulligan; W L George; S M Finegold
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

6.  Doxycycline in abdominal surgery.

Authors:  R A Klein; D F Busch; S E Wilson; D J Flora; S M Finegold
Journal:  JAMA       Date:  1977-10-31       Impact factor: 56.272

7.  Erythromycin for anaerobic pleuropulmonary and soft-tissue infections.

Authors:  E J Goldstein; R P Lewis; V L Sutter; S M Finegold
Journal:  JAMA       Date:  1979-08-03       Impact factor: 56.272

8.  Bacteroides bacteremia. Analysis of 142 episodes from one metropolitan area.

Authors:  C S Bryan; K L Reynolds; B Kirkhart; J J Brown
Journal:  Arch Surg       Date:  1984-08

9.  Intravenous metronidazole for treatment of infections involving anaerobic bacteria.

Authors:  W L George; B D Kirby; V L Sutter; L A Wheeler; M E Mulligan; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

10.  Bacteremia due to Bacteroidacceae: a review of 92 cases.

Authors:  R G Mathias; G K Harding; M J Gurwith; H G Stiver; E Sigurdson; C A Gratton; A R Ronald
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

View more
  2 in total

Review 1.  Non-canonical mechanisms of antibiotic resistance.

Authors:  J L Martínez; J Blázquez; F Baquero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

2.  Antimicrobial resistance in human oral and intestinal anaerobic microfloras.

Authors:  C A Stark; C Edlund; S Sjöstedt; G Kristensen; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.